Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-γ and tumor necrosis factor-α in human thyroid carcinoma cells

International Immunology

Volumn 13, Issue 11, 2001, Pages 1423-1432

  Rahat, M A ^a   Chernichovski, I ^a   Lahat, N ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

Class II transactivator; HLA DR; IFN regulating factor 1; IFN ; NF B; Signal transducer and activator of transcription 1; Thyroid; Tumor necrosis factor ; USF 1

Indexed keywords

CLASS II TRANSACTIVATOR; GAMMA INTERFERON; HLA DR ALPHA ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; STAT PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROMOTER; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CARCINOMA CELL; CELL TYPE; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INCUBATION TIME; MOLECULAR DYNAMICS; MRO 87 1 CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THYROID CARCINOMA; THYROID CELL; TRANSCRIPTION REGULATION;

EID: 0035172887     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/13.11.1423     Document Type: Article

References (40)

1. Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and la molecules
2. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases
3. h2 immunity
4. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease. Relevance for autoimmunity
5. Gene products of the HLA-D region in malignant and normal tissue of non lymphoid origin
6. Expression of HLA-ABC and DR antigen in thyroid neoplasia and correlation with mononuclear leukocyte infiltration
7. HLA class II antigen expression and the autoimmune thyroid response in patients with benign and malignant thyroid tumor
8. Significance and regulation of the expression of MHC class II molecules on autoimmune and neoplastic thyroid cells
9. Sequences and factors: A guide to MHC class II transcription
10. Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet
11. Regulation of MHC class II genes: Lessons from a disease
12. Regulation of MHC gene expression
13. Transcriptional regulation of the HLA-DRA Gene
14. CREB regulates MHC class II expression in a CIITA-dependent manner
15. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
16. The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes
17. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency
18. Transcriptional scaffold: CIITA interacts with NF-Y, RFX and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter
19. CIITA is transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex
20. Expression of MHC class II molecules in different cellular and functional compartments is controlled by different usage of multiple promoters of the transactivator CIITA
21. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between STAT-1 and USF-1
22. IFN-γ regulation of the type IV class II transactivator promoter in astrocytes
23. A new cytokine (IK) down-regulating HLA class II: Monoclonal antibodies, cloning and chromosome localization
24. Inhibitor (IK) of IFN-gamma induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line
25. Divergent effects of cytokines on human leukocyte antigen-DR antigen expression of neoplastic and non-neoplastic human thyroid cells
26. Control of HLA-DR antigen expression by γ-interferon: Separate signal transduction mechanisms in malignant and nonmalignant human thyroid cells
27. HLA-DRα gene regulation in immortalized human thyroid cancer cells
28. HLA-DMB expression by thyrocytes: Indication of the antigen-processing and possible presenting capability of thyroid cells
29. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
30. Rapid test for in vivo stability and DNA binding of mutated octamer binding proteins with 'mini-extracts' prepared from transfected cells
31. Activation of IFN-γ element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis
32. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-α on IFN-γ-induced HLA-DR and la expression depends on the maturation and differentiation stage of the cell
33. TNF-α suppresses IFN-γ-induced MHC class II expression in HT1080 cells by destabilizing Class II transactivator mRNA
34. Differential selectivity of CIITA promoter activation by IFN-γ and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-α
35. Cellular responses to interferon-γ
36. Double-stranded RNA-dependent protein kinase activates transcription factors NF-κB by phosphorylating IkB
37. Synergitic activation of NF-κB by TNF-α and IFn-γ via enhanced IκBα degradation and de novo IκBα degradation
38. Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-γ and TNF-α in oligodendrocytes
39. Induction of transcription factor interferon regulatory factor-1 by IFN-γ and TNF-α in FRTL-5 cells
40. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types